Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Oncology and Translational Medicine is Scopus-indexed (Q3, CiteScore 1.3), DOAJ. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 2095-9621Verify ISSN ↗2995-5858Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 320 / 428 | 25th | Q3 |
| Immunology | 211 / 243 | 13th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q3, CiteScore 1.3.
Oncology and Translational Medicine is Q3 in Oncology (rank 320 of 428) and Q4 in Immunology (rank 211 of 243), by CiteScore 2025.
Oncology and Translational Medicine is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.3, quartile Q3, 25th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.275, quartile Q4, with an H-index of 6.
Oncology and Translational Medicine is published by Lippincott Williams and Wilkins. Its print ISSN is 2095-9621 and its online ISSN is 2995-5858.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Oncology and Translational Medicine has an h-index of 11 and a 2-year mean of 3.39 citations per paper (OpenAlex). Its Scopus CiteScore is 1.3, quartile Q3. On 2-year citations it ranks #94 of 424 Scopus journals in Oncology.
Oncology and Translational Medicine published 43 papers in 2025; its busiest recent year was 2018 with 53. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 88 research articles (2024–2026), authors are most often from China (83.9%), Indonesia (3.4%) and India (2.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.